AMENDMENT NO. 2 TO LICENSE AND SUPPLY AGREEMENTLicense and Supply Agreement • November 9th, 2020 • Recro Pharma, Inc. • Pharmaceutical preparations
THIS AMENDMENT NO. 2 TO LICENSE AND SUPPLY AGREEMENT (this “Amendment”) is made as of November 5, 2020 by and between Recro Gainesville LLC (as successor to Alkermes Pharma Ireland Limited) (“Recro”), Kremers Urban Pharmaceuticals, Inc. (“Kremers Urban”) and Lannett Company, Inc. (“Lannett”).
FOURTH AMENDMENT TO CREDIT AGREEMENT AND INVESTMENT DOCUMENTSCredit Agreement and Investment Documents • November 9th, 2020 • Recro Pharma, Inc. • Pharmaceutical preparations • New York
THIS FOURTH AMENDMENT TO CREDIT AGREEMENT AND INVESTMENT DOCUMENTS (this “Agreement”), dated as of November 5, 2020 (the “Fourth Amendment Effective Date”), is entered into among RECRO PHARMA, INC., a Pennsylvania corporation (the “Borrower”), the Guarantors party hereto, the Lenders party hereto (including in their capacity as holders of the Warrants) and ATHYRIUM OPPORTUNITIES III ACQUISITION LP, as Administrative Agent (the “Administrative Agent”). All capitalized terms used herein and not otherwise defined herein shall have the meanings given to such terms in the Credit Agreement (as defined below).
